Medivolve Inc.
MEDVF
$0.002
$0.000.00%
OTC PK
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 46.27% | 32.00% | 7.42% | -410.42% | -1,205.48% |
| Total Depreciation and Amortization | -111.01% | -102.41% | -86.09% | -61.86% | -21.20% |
| Total Amortization of Deferred Charges | -50.11% | -50.11% | 59.18% | 59.18% | 59.18% |
| Total Other Non-Cash Items | -34.67% | -15.21% | -78.29% | -65.79% | -28.82% |
| Change in Net Operating Assets | 11.29% | -90.39% | 105.75% | 128.90% | 113.35% |
| Cash from Operations | 90.86% | -133.41% | -146.73% | -115.34% | -207.26% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 41.42% | -- |
| Total Debt Issued | -100.00% | -- | 2,714.38% | -63.02% | -63.02% |
| Total Debt Repaid | 97.07% | -42.61% | -619.68% | -251.44% | -249.67% |
| Issuance of Common Stock | -- | -- | -100.00% | -100.00% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 96.57% | 83.80% | 16.67% | -138.99% | -151.04% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 88.99% | -160.08% | -174.38% | -122.88% | -182.99% |